HOUSTON – (July 10, 2024) – The Controlled Release Society (CRS), the premier international, multidisciplinary society dedicated to the science and technology of drug delivery, has elected Rice University bioengineer Omid Veiseh to its College of Fellows.
Credit: Photo by Gustavo Raskosky/Rice University
HOUSTON – (July 10, 2024) – The Controlled Release Society (CRS), the premier international, multidisciplinary society dedicated to the science and technology of drug delivery, has elected Rice University bioengineer Omid Veiseh to its College of Fellows.
The recognition is a prestigious acknowledgement of “outstanding and sustained contributions in the field of delivery science and technology,” according to the organization website.
“I am deeply honored to be elected to the CRS College of Fellows and to join a distinguished community of fellow researchers, educators and industry leaders,” said Veiseh, a professor of bioengineering, a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar and faculty director of the Rice Biotech Launch Pad, a Houston-based accelerator focused on expediting the translation of the university’s health and medical technology discoveries into cures.
“We believe this is an exciting time for the field of delivery science,” Veiseh added. “I look forward to continuing to advance the field through my ongoing research, innovative collaborations and the collective efforts of the esteemed members of the CRS College of Fellows.”
The CRS serves more than 1,500 members from over 50 countries. The 2024 cohort of fellows was formally recognized at the CRS Annual Meeting held in Bologna, Italy.
-30-
This news release can be found online at news.rice.edu.
Follow Rice News and Media Relations via Twitter @RiceUNews.
Image downloads:
CAPTION: Omid Veiseh is a professor of bioengineering at Rice Univesity, a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar and faculty director of the Rice Biotech Launch Pad. (Photo by Gustavo Raskosky/Rice University)
About the Rice Biotech Launch Pad:
The Rice Biotech Launch Pad is a Houston-based accelerator focused on expediting the translation of Rice University’s health and medical technology discoveries into cures. This initiative is designed to help advance internally discovered platform technologies from concept to clinical studies and commercialization. The Rice Biotech Launch Pad will identify and support highly differentiated projects while driving the expansion of Houston as a world-class medical innovation ecosystem. The accelerator will bring together local researchers with a network of industry executives. For more information, please visit .
About Rice:
Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of architecture, business, continuing studies, engineering, humanities, music, natural sciences and social sciences and is home to the Baker Institute for Public Policy. With 4,574 undergraduates and 3,982 graduate students, Rice’s undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction, No. 2 for best-run colleges and No. 12 for quality of life by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger’s Personal Finance.
